Rating History for Boston Scientific (bsx) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/29/2026 | Mike Polark | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
49.11 (51.83) |
5.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/29/2026 | Mike Polark | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
49.11 (51.83) |
5.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||